Search

everythinglearnresearchcommunity

for

Search:↓

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Hair levels of estradiol and progesterone are higher in premenopausal than postmenopausal women, but the difference isn't statistically significant, indicating the need for a better measurement method.

The compound was successfully made and shows potential for treating prostate cancer.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Sterculia foetida seed extract shows promise for therapeutic use due to its anti-inflammatory and pain-relief properties.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Tiny lipid particles loaded with a hormone gather in hair follicles, which may help treat hair loss.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Hair can reliably measure average estradiol levels over months in humans and monkeys.

Medroxyprogesterone acetate improved sleep apnea symptoms in some obese patients.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

Letrozole may help prevent seizures by reducing certain hormone levels.

Estrogen receptors may not affect mouse hair growth as previously thought, and oxybenzone in sunscreen is stable in sunlight.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

The ethosomal delivery system improves topical drug delivery and promotes hair growth.

TM-β-CD improves finasteride's solubility and delivery, while β-CD offers better long-term release.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

The combined therapy improved symptoms in PCOS patients.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Most women had adequate essential elements except zinc, and lead levels were higher in peri-/post-menopausal women.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.